Table 6.
Variable | Adjusted OR | 95% CI | p Value |
---|---|---|---|
Age | 0.99 | 0.98 to 1.03 | 0.16 |
Male gender | 0.78 | 0.59 to 1.04 | 0.09 |
DM II | 1.06 | 0.79 to 1.41 | 0.70 |
CKD | 1.31 | 0.91 to 1.89 | 0.15 |
COPD/asthma | 0.64 | 0.37 to 1.10 | 0.11 |
STEMI | 2.25 | 1.57 to 3.23 | 0.001 |
LVEF≥35% | 0.77 | 0.59 to 1.01 | 0.06 |
LVEF<35 | 1.30 | 0.99 to 1.70 | 0.06 |
VHD | 1.59 | 1.12 to 2.25 | 0.009 |
Stroke | 1.71 | 1.13 to 2.60 | 0.01 |
PVD | 1.52 | 0.89 to 2.62 | 0.13 |
Multivariate logistic regression analysis for 1-year mortality | |||
Age | 1.04 | 1.03 to 1.05 | 0.001 |
Male gender | 1.12 | 0.90 to 1.40 | 0.31 |
DM II | 1.18 | 0.95 to 1.46 | 0.13 |
CKD | 1.53 | 1.19 to 1.96 | 0.001 |
COPD/asthma | 1.22 | 0.91 to 1.65 | 0.19 |
STEMI | 0.89 | 0.62 to 1.29 | 0.55 |
LVEF≥35 | 0.74 | 0.60 to 0.91 | 0.005 |
LVEF<35 | 1.35 | 1.10 to 1.67 | 0.005 |
VHD | 1.46 | 1.10 to 1.93 | 0.009 |
Stroke | 1.34 | 0.98 to 1.84 | 0.07 |
PVD | 1.20 | 0.79 to 1.82 | 0.41 |
Risk factors for stroke in heart failure | |||
Age | 1.02 | 1.01 to 1.03 | 0.001 |
Gender | 1.02 | 0.81 to 1.28 | 0.88 |
DM | 1.30 | 1.01 to 1.69 | 0.045 |
HTN | 2.10 | 1.50 to 2.80 | 0.001 |
Systolic BP | 1.0 | 0.99 to 1.01 | 0.51 |
Diastolic BP | 1.0 | 0.99 to 1.01 | 0.65 |
NYHA I | 0.64 | 0.19 to 2.14 | 0.33 |
NYHA II | 0.98 | 0.42 to 2.25 | 0.46 |
NYHA III | 1.24 | 0.55 to 2.80 | 0.95 |
NYHA IV | 1.24 | 0.54 to 2.81 | 0.61 |
Hyperlipidaemia | 1.30 | 1.02 to 1.65 | 0.03 |
CKD | 1.31 | 1.05 to 1.75 | 0.045 |
Systolic LV dysfunction | 1.08 | 0.85 to 1.37 | 0.52 |
Known CAD | 1.14 | 0.89 to 1.47 | 0.30 |
PVD (%) | 2.97 | 2.06 to 4.12 | 0.001 |
AF | 2.20 | 1.67 to 2.89 | 0.001 |
Thyroid disease | 0.91 | 0.56 to 1.49 | 0.71 |
AF, atrial fibrillation; BP, blood pressure; CAD, coronary artery disease; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; HTN, hypertension; LV, left ventricular; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association; PVD, peripheral vascular disease; TIA, transient ischaemic attack; VHD, valvular heart disease.